149-LB: Telemedicine Intervention Impact on Diabetes Self-Management—Twelve-Month Virtual Diabetes Specialty Clinic (VDISC) Study Outcomes

The impact of a telemedicine model for a virtual diabetes clinic was assessed 6 months following completion of a 6-month intervention of education and support for diabetes self-management, including initiation and use of CGM. One hundred and sixty-one participants ≥18 years old with T1D (N=109) or T...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes (New York, N.Y.) N.Y.), 2023-06, Vol.72 (Supplement_1), p.1
Hauptverfasser: GAL, ROBIN L., RAGHINARU, DAN, ALEPPO, GRAZIA, OLSON, BETH A., KRUGER, DAVIDA F., BERGENSTAL, RICHARD M., WEINSTOCK, RUTH S., BRADSHAW, AMY, MCARTHUR, TERESA S., OSER, SEAN, OSER, TAMARA, HOOD, KOREY K., CUSHMAN, TERRA L., JOHNSON, MARY L., KOLLMAN, CRAIG, BECK, ROY
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue Supplement_1
container_start_page 1
container_title Diabetes (New York, N.Y.)
container_volume 72
creator GAL, ROBIN L.
RAGHINARU, DAN
ALEPPO, GRAZIA
OLSON, BETH A.
KRUGER, DAVIDA F.
BERGENSTAL, RICHARD M.
WEINSTOCK, RUTH S.
BRADSHAW, AMY
MCARTHUR, TERESA S.
OSER, SEAN
OSER, TAMARA
HOOD, KOREY K.
CUSHMAN, TERRA L.
JOHNSON, MARY L.
KOLLMAN, CRAIG
BECK, ROY
description The impact of a telemedicine model for a virtual diabetes clinic was assessed 6 months following completion of a 6-month intervention of education and support for diabetes self-management, including initiation and use of CGM. One hundred and sixty-one participants ≥18 years old with T1D (N=109) or T2D (N=52) using MDI/pump participated in the 12-month study. At the end of the 6-month intervention period, mean HbA1c decreased from 7.6% at baseline to 7.0% in T1D and from 8.1% to 7.0% in T2D (P
doi_str_mv 10.2337/db23-149-LB
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2849360654</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2849360654</sourcerecordid><originalsourceid>FETCH-LOGICAL-c644-f3d72cdf6dac6f5f48b37df43cf2893004a6b2ec827336b6539ff8e9fa4e8cb93</originalsourceid><addsrcrecordid>eNpNkL1OwzAURi0EEqUw8QKWWEDI4NhuErPRlp9KrTo0qtgix7kGV4lTEqeoGw_AyBPyJKQqA7rDvcO53ycdhM4DesM4j27zjHESCEmmwwPUCySXhLPo5RD1KA0YCSIZHaOTpllRSsNueuhrT9_hBAooIbfaOsAT56HegPO2cnhSrpX2uLvGVmXgocELKAyZKadeux_nfz6_kw8oNkBmlfNveGlr36riH78GbVXht3hUWGc1vlyOJ4vRFV74Nt_ieet1VUJzio6MKho4-9t9lDw-JKNnMp0_TUb3U6JDIYjhecR0bsJc6dAMjIgzHuVGcG1YLDmlQoUZAx2ziPMwCwdcGhODNEpArDPJ--hiH7uuq_cWGp-uqrZ2XWPKYiF5Z2YgOup6T-m6apoaTLqubanqbRrQdGc73dlOO3_pdMh_AT-idGU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2849360654</pqid></control><display><type>article</type><title>149-LB: Telemedicine Intervention Impact on Diabetes Self-Management—Twelve-Month Virtual Diabetes Specialty Clinic (VDISC) Study Outcomes</title><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>GAL, ROBIN L. ; RAGHINARU, DAN ; ALEPPO, GRAZIA ; OLSON, BETH A. ; KRUGER, DAVIDA F. ; BERGENSTAL, RICHARD M. ; WEINSTOCK, RUTH S. ; BRADSHAW, AMY ; MCARTHUR, TERESA S. ; OSER, SEAN ; OSER, TAMARA ; HOOD, KOREY K. ; CUSHMAN, TERRA L. ; JOHNSON, MARY L. ; KOLLMAN, CRAIG ; BECK, ROY</creator><creatorcontrib>GAL, ROBIN L. ; RAGHINARU, DAN ; ALEPPO, GRAZIA ; OLSON, BETH A. ; KRUGER, DAVIDA F. ; BERGENSTAL, RICHARD M. ; WEINSTOCK, RUTH S. ; BRADSHAW, AMY ; MCARTHUR, TERESA S. ; OSER, SEAN ; OSER, TAMARA ; HOOD, KOREY K. ; CUSHMAN, TERRA L. ; JOHNSON, MARY L. ; KOLLMAN, CRAIG ; BECK, ROY</creatorcontrib><description><![CDATA[The impact of a telemedicine model for a virtual diabetes clinic was assessed 6 months following completion of a 6-month intervention of education and support for diabetes self-management, including initiation and use of CGM. One hundred and sixty-one participants ≥18 years old with T1D (N=109) or T2D (N=52) using MDI/pump participated in the 12-month study. At the end of the 6-month intervention period, mean HbA1c decreased from 7.6% at baseline to 7.0% in T1D and from 8.1% to 7.0% in T2D (P<0.001). At 12 months (6 months after discontinuation of the intervention), mean HbA1c was 7.0% for T1D and 7.2% for T2D (P<0.001 compared with baseline). Mean time in range 70-180 mg/dL was 51% at baseline, increasing to 62% at 6 months (P<0.001) and 64% at 12 months in T1D (P<0.001) and from 49% to 66% (P<0.001) and 68% (P<0.001), respectively, in T2D. Similar improvements were observed for mean glucose and hyperglycemia metrics. A sustained reduction in hypoglycemia also was observed. The virtual diabetes clinic intervention was successful in promoting improved glycemic outcomes, which were sustained 6 months after the intervention was completed. These findings demonstrate the impact that virtual care and education can have on self-management over time and provide opportunity to expand care models that could minimize barriers to specialty care access.]]></description><identifier>ISSN: 0012-1797</identifier><identifier>EISSN: 1939-327X</identifier><identifier>DOI: 10.2337/db23-149-LB</identifier><language>eng</language><publisher>New York: American Diabetes Association</publisher><subject>Diabetes ; Diabetes mellitus ; Hyperglycemia ; Hypoglycemia ; Telemedicine</subject><ispartof>Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1</ispartof><rights>Copyright American Diabetes Association Jun 2023</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>GAL, ROBIN L.</creatorcontrib><creatorcontrib>RAGHINARU, DAN</creatorcontrib><creatorcontrib>ALEPPO, GRAZIA</creatorcontrib><creatorcontrib>OLSON, BETH A.</creatorcontrib><creatorcontrib>KRUGER, DAVIDA F.</creatorcontrib><creatorcontrib>BERGENSTAL, RICHARD M.</creatorcontrib><creatorcontrib>WEINSTOCK, RUTH S.</creatorcontrib><creatorcontrib>BRADSHAW, AMY</creatorcontrib><creatorcontrib>MCARTHUR, TERESA S.</creatorcontrib><creatorcontrib>OSER, SEAN</creatorcontrib><creatorcontrib>OSER, TAMARA</creatorcontrib><creatorcontrib>HOOD, KOREY K.</creatorcontrib><creatorcontrib>CUSHMAN, TERRA L.</creatorcontrib><creatorcontrib>JOHNSON, MARY L.</creatorcontrib><creatorcontrib>KOLLMAN, CRAIG</creatorcontrib><creatorcontrib>BECK, ROY</creatorcontrib><title>149-LB: Telemedicine Intervention Impact on Diabetes Self-Management—Twelve-Month Virtual Diabetes Specialty Clinic (VDISC) Study Outcomes</title><title>Diabetes (New York, N.Y.)</title><description><![CDATA[The impact of a telemedicine model for a virtual diabetes clinic was assessed 6 months following completion of a 6-month intervention of education and support for diabetes self-management, including initiation and use of CGM. One hundred and sixty-one participants ≥18 years old with T1D (N=109) or T2D (N=52) using MDI/pump participated in the 12-month study. At the end of the 6-month intervention period, mean HbA1c decreased from 7.6% at baseline to 7.0% in T1D and from 8.1% to 7.0% in T2D (P<0.001). At 12 months (6 months after discontinuation of the intervention), mean HbA1c was 7.0% for T1D and 7.2% for T2D (P<0.001 compared with baseline). Mean time in range 70-180 mg/dL was 51% at baseline, increasing to 62% at 6 months (P<0.001) and 64% at 12 months in T1D (P<0.001) and from 49% to 66% (P<0.001) and 68% (P<0.001), respectively, in T2D. Similar improvements were observed for mean glucose and hyperglycemia metrics. A sustained reduction in hypoglycemia also was observed. The virtual diabetes clinic intervention was successful in promoting improved glycemic outcomes, which were sustained 6 months after the intervention was completed. These findings demonstrate the impact that virtual care and education can have on self-management over time and provide opportunity to expand care models that could minimize barriers to specialty care access.]]></description><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Hyperglycemia</subject><subject>Hypoglycemia</subject><subject>Telemedicine</subject><issn>0012-1797</issn><issn>1939-327X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNpNkL1OwzAURi0EEqUw8QKWWEDI4NhuErPRlp9KrTo0qtgix7kGV4lTEqeoGw_AyBPyJKQqA7rDvcO53ycdhM4DesM4j27zjHESCEmmwwPUCySXhLPo5RD1KA0YCSIZHaOTpllRSsNueuhrT9_hBAooIbfaOsAT56HegPO2cnhSrpX2uLvGVmXgocELKAyZKadeux_nfz6_kw8oNkBmlfNveGlr36riH78GbVXht3hUWGc1vlyOJ4vRFV74Nt_ieet1VUJzio6MKho4-9t9lDw-JKNnMp0_TUb3U6JDIYjhecR0bsJc6dAMjIgzHuVGcG1YLDmlQoUZAx2ziPMwCwdcGhODNEpArDPJ--hiH7uuq_cWGp-uqrZ2XWPKYiF5Z2YgOup6T-m6apoaTLqubanqbRrQdGc73dlOO3_pdMh_AT-idGU</recordid><startdate>20230620</startdate><enddate>20230620</enddate><creator>GAL, ROBIN L.</creator><creator>RAGHINARU, DAN</creator><creator>ALEPPO, GRAZIA</creator><creator>OLSON, BETH A.</creator><creator>KRUGER, DAVIDA F.</creator><creator>BERGENSTAL, RICHARD M.</creator><creator>WEINSTOCK, RUTH S.</creator><creator>BRADSHAW, AMY</creator><creator>MCARTHUR, TERESA S.</creator><creator>OSER, SEAN</creator><creator>OSER, TAMARA</creator><creator>HOOD, KOREY K.</creator><creator>CUSHMAN, TERRA L.</creator><creator>JOHNSON, MARY L.</creator><creator>KOLLMAN, CRAIG</creator><creator>BECK, ROY</creator><general>American Diabetes Association</general><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20230620</creationdate><title>149-LB: Telemedicine Intervention Impact on Diabetes Self-Management—Twelve-Month Virtual Diabetes Specialty Clinic (VDISC) Study Outcomes</title><author>GAL, ROBIN L. ; RAGHINARU, DAN ; ALEPPO, GRAZIA ; OLSON, BETH A. ; KRUGER, DAVIDA F. ; BERGENSTAL, RICHARD M. ; WEINSTOCK, RUTH S. ; BRADSHAW, AMY ; MCARTHUR, TERESA S. ; OSER, SEAN ; OSER, TAMARA ; HOOD, KOREY K. ; CUSHMAN, TERRA L. ; JOHNSON, MARY L. ; KOLLMAN, CRAIG ; BECK, ROY</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c644-f3d72cdf6dac6f5f48b37df43cf2893004a6b2ec827336b6539ff8e9fa4e8cb93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Hyperglycemia</topic><topic>Hypoglycemia</topic><topic>Telemedicine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>GAL, ROBIN L.</creatorcontrib><creatorcontrib>RAGHINARU, DAN</creatorcontrib><creatorcontrib>ALEPPO, GRAZIA</creatorcontrib><creatorcontrib>OLSON, BETH A.</creatorcontrib><creatorcontrib>KRUGER, DAVIDA F.</creatorcontrib><creatorcontrib>BERGENSTAL, RICHARD M.</creatorcontrib><creatorcontrib>WEINSTOCK, RUTH S.</creatorcontrib><creatorcontrib>BRADSHAW, AMY</creatorcontrib><creatorcontrib>MCARTHUR, TERESA S.</creatorcontrib><creatorcontrib>OSER, SEAN</creatorcontrib><creatorcontrib>OSER, TAMARA</creatorcontrib><creatorcontrib>HOOD, KOREY K.</creatorcontrib><creatorcontrib>CUSHMAN, TERRA L.</creatorcontrib><creatorcontrib>JOHNSON, MARY L.</creatorcontrib><creatorcontrib>KOLLMAN, CRAIG</creatorcontrib><creatorcontrib>BECK, ROY</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>Diabetes (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>GAL, ROBIN L.</au><au>RAGHINARU, DAN</au><au>ALEPPO, GRAZIA</au><au>OLSON, BETH A.</au><au>KRUGER, DAVIDA F.</au><au>BERGENSTAL, RICHARD M.</au><au>WEINSTOCK, RUTH S.</au><au>BRADSHAW, AMY</au><au>MCARTHUR, TERESA S.</au><au>OSER, SEAN</au><au>OSER, TAMARA</au><au>HOOD, KOREY K.</au><au>CUSHMAN, TERRA L.</au><au>JOHNSON, MARY L.</au><au>KOLLMAN, CRAIG</au><au>BECK, ROY</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>149-LB: Telemedicine Intervention Impact on Diabetes Self-Management—Twelve-Month Virtual Diabetes Specialty Clinic (VDISC) Study Outcomes</atitle><jtitle>Diabetes (New York, N.Y.)</jtitle><date>2023-06-20</date><risdate>2023</risdate><volume>72</volume><issue>Supplement_1</issue><spage>1</spage><pages>1-</pages><issn>0012-1797</issn><eissn>1939-327X</eissn><abstract><![CDATA[The impact of a telemedicine model for a virtual diabetes clinic was assessed 6 months following completion of a 6-month intervention of education and support for diabetes self-management, including initiation and use of CGM. One hundred and sixty-one participants ≥18 years old with T1D (N=109) or T2D (N=52) using MDI/pump participated in the 12-month study. At the end of the 6-month intervention period, mean HbA1c decreased from 7.6% at baseline to 7.0% in T1D and from 8.1% to 7.0% in T2D (P<0.001). At 12 months (6 months after discontinuation of the intervention), mean HbA1c was 7.0% for T1D and 7.2% for T2D (P<0.001 compared with baseline). Mean time in range 70-180 mg/dL was 51% at baseline, increasing to 62% at 6 months (P<0.001) and 64% at 12 months in T1D (P<0.001) and from 49% to 66% (P<0.001) and 68% (P<0.001), respectively, in T2D. Similar improvements were observed for mean glucose and hyperglycemia metrics. A sustained reduction in hypoglycemia also was observed. The virtual diabetes clinic intervention was successful in promoting improved glycemic outcomes, which were sustained 6 months after the intervention was completed. These findings demonstrate the impact that virtual care and education can have on self-management over time and provide opportunity to expand care models that could minimize barriers to specialty care access.]]></abstract><cop>New York</cop><pub>American Diabetes Association</pub><doi>10.2337/db23-149-LB</doi></addata></record>
fulltext fulltext
identifier ISSN: 0012-1797
ispartof Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1
issn 0012-1797
1939-327X
language eng
recordid cdi_proquest_journals_2849360654
source EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Diabetes
Diabetes mellitus
Hyperglycemia
Hypoglycemia
Telemedicine
title 149-LB: Telemedicine Intervention Impact on Diabetes Self-Management—Twelve-Month Virtual Diabetes Specialty Clinic (VDISC) Study Outcomes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T10%3A28%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=149-LB:%20Telemedicine%20Intervention%20Impact%20on%20Diabetes%20Self-Management%E2%80%94Twelve-Month%20Virtual%20Diabetes%20Specialty%20Clinic%20(VDISC)%20Study%20Outcomes&rft.jtitle=Diabetes%20(New%20York,%20N.Y.)&rft.au=GAL,%20ROBIN%20L.&rft.date=2023-06-20&rft.volume=72&rft.issue=Supplement_1&rft.spage=1&rft.pages=1-&rft.issn=0012-1797&rft.eissn=1939-327X&rft_id=info:doi/10.2337/db23-149-LB&rft_dat=%3Cproquest_cross%3E2849360654%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2849360654&rft_id=info:pmid/&rfr_iscdi=true